Filing Flows › Lucid Diagnostics (LUCD) › Recalls, complaints & regulation
Lucid Diagnostics (LUCD): recalls and clinical trials
Lucid Diagnostics (LUCD) beyond its filings: 0 recalls in the last 12 months (2 in five years, 0 Class I); 2 active clinical trials.
Latest recalls
- 2024-06-05 · FDA device · Brand Name: EsophaCap Product Name: EsophaCap (25mm diameter, 10 pores/inch) Model/Catalog Number: EC25T10VI Software Version: N/A Product Description: Esop
- 2024-06-05 · FDA device · Brand Name: EsophaCap Product Name: EsophaCap (20mm diameter, 20 pores/inch) Model/Catalog Number: EC20T20VI Software Version: N/A Product Description: Esop
Lucid Diagnostics' latest quarter
Lucid Diagnostics, Q2 2026: revenue $1.5M (+27% year over year), operating margin -868.5%, net loss $11.7M, operating cash flow −$11.3M. The chart follows the revenue to costs, profit and cash.
Questions
Has Lucid Diagnostics had any recalls?
2 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
How many clinical trials does Lucid Diagnostics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.